AWM
ADPT icon

Accurate Wealth Management’s Adaptive Biotechnologies ADPT Stock Holding History

Accurate Wealth Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-92
Closed -$822 – 264
2022
Q4 		$822 Buy
+92
New +$716 ﹤0.01% 1412

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Accurate Wealth Management's ADPT Position: Q1 2023 in Review

Accurate Wealth Management sold out of Adaptive Biotechnologies (ADPT) in Q1 2023, closing a stake of 92 shares — an estimated $822 sold.

Accurate Wealth Management first reported a position in ADPT in Q4 2022 and held it in 1 quarter. The position peaked at $822 in Q4 2022. 226 funds tracked by Wall St. Rank hold ADPT as of Q1 2023.

  • Accurate Wealth Management reported no remaining Adaptive Biotechnologies position as of Q1 2023 after selling out during the quarter.
  • Accurate Wealth Management sold 92 Adaptive Biotechnologies shares in Q1 2023, an estimated $822.
  • Accurate Wealth Management first reported a position in Adaptive Biotechnologies in Q4 2022 and held it in 1 quarter.
  • Accurate Wealth Management's Adaptive Biotechnologies position peaked at $822 in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2023.

Based on Accurate Wealth Management's 13F filing for Q1 2023, filed 13 Apr 2023.